WHO reported Middle East respiratory syndrome coronavirus outbreak continues
On Dec. 24, 2025, the World Health Organization (WHO) reported that since the beginning of 2025 and as…
On Dec. 24, 2025, the World Health Organization (WHO) reported that since the beginning of 2025 and as…
On May 12, 2025, the the Ministry of Health (MoH) of the Kingdom of Saudi Arabia (KSA) reported…
On Oct. 11, 2024, the World Health Organization (WHO) reported that a total of 58 cases of Marburg…
On Oct. 2, 2024, the World Health Organization (WHO) announced it had been notified of one human case…
On Apr. 10, 2024, LabCorp announced that the U.S. Food and Drug Administration (FDA) had granted Emergency Use…
On Mar. 27, 2024, the World Health Organization announced it had launched a network for coronaviruses, CoViNet, to…
On Jul. 24, 2023, the United Arab Emirates (UAE), notified WHO of a case of Middle East Respiratory…
On Aug. 4, 2021, Inovio Pharma announced that the company had dosed the first Phase 2 trial subject…
On Apr. 19, 2021, Tonix Pharmaceuticals and OyaGen announced an exclusive worldwide licensing agreement for an antiviral inhibitor…
On Feb. 23, 2021, the NIH announced that a randomized, placebo-controlled Phase 1 clinical trial of two monoclonal…
On Oct. 27, 2020, researchers at Yale University and the Broad Institute of MIT and Harvard screened hundred…
On Aug. 31, 2020, BioCryst Pharmaceuticals announced that the National Institute of Allergy and Infectious Diseases (NIAID) had…
On Jul. 7, 2020, Cerus announced study results that demonstrated the INTERCEPT Blood System inactivates SARS-CoV-2, the causative…
On Jun. 11, 2020, Innovation Pharma announced the Company and researchers at a U.S. Regional Biocontainment Laboratory (RBL)…
On Jun. 11, 2020, BioCryst Pharmaceuticals announced new data published in Science Translational Medicine that show, in a…
On May 19, 2020, the National Institutes of Health (NIH) reported that researchers from the University of Texas,…
On Apr. 30, 2020, INOVIO announced an agreement to expand its manufacturing partnership with the German contract manufacturer…
On Apr. 28, 2020, INOVIO and GeneOne Life Science announced interim data through week 16 from a Phase 1/2a…
On Apr. 17, 2020, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to…
On Apr. 14, 2020, researchers from the University of Pittsburgh announced that they had adapted a system to…
On Apr. 7, 2020, researchers at the University of Iowa and the University of Georgia announced they had…
On Apr. 6, 2020, VGX announced successful implementation of new RNA production services through completion of all Phase…
On Mar. 31, 2020, VBI Vaccines announced a collaboration with the National Research Council of Canada (NRC) to…
On Mar. 25, 2020, physician-scientists at four University of California Health medical centers — UC San Diego Health,…
On May 12, 2022, the National IHR Focal Point for Qatar reported two laboratory-confirmed cases of Middle East…
On Mar. 12, 2020, Predictive Oncology announced it will launch a new AI platform for vaccine and drug…
On Feb. 13, 2020, National Institutes of Health (NIH) scientists announced that the experimental antiviral remdesivir successfully prevented…
On Dec. 20, 2019, Vaccitech’s partner, the University of Oxford’s Jenner Institute, in collaboration with The King Abdullah…
On Sept. 27, 2018, CEPI (the Coalition for Epidemic Preparedness Innovations) announced a collaboration with The Jenner Institute…
On May 1, 2014, the first U.S. imported case of Middle East Respiratory Syndrome (MERS) was confirmed in…